DILIN - Prospective Study (NCT00345930)
A Multi-Center, Longitudinal Study of Drug-and CAM-Induced Liver Injury
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to identify individuals who have suffered a liver injury arising as an idiosyncratic reaction to a prescription drug or a complementary and alternative medicine. Recently added acute cases enrollment that meets criteria to the protocol. Also added Fibroscans to the protocol that will be completed at baseline and follow-up on chronic subjects.
Who can join: Review the eligibility criteria below.
Location: University of Southern California — Los Angeles, California
Age range: 2 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (6 Sites)
- University of Southern California — Los Angeles, California
- Indiana University — Indianapolis, Indiana
- NIH Clinical Site — Bethesda, Maryland
- University of Michigan — Ann Arbor, Michigan
- Univeristy of North Carolina at Chapel Hill — Chapel Hill, North Carolina
- Thomas Jefferson — Philadelphia, Pennsylvania
📞 Contact the Study Coordinator
Phone: (919) 660-7253
Email: eilene.pham@duke.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Liver Diseases
- Coronavirus Disease 2019 (Covid-19) Impact on Alcohol-related Liver Disease Patient Outcomes, Care and Alcohol Use — San Francisco, California
- Liver Cancer Prevention Randomized Control Trial — Houston, Texas
- RESTORE Declined Livers Study — St Louis, Missouri
- Liver Micro Flow - MRI — Madison, Wisconsin
- The Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) Trial — Chicago, Illinois
- MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease — Chicago, Illinois
Explore by condition: All Liver Diseases clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.